Kim Thi Can Ho, OD
Optometrist · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ho’s office at (650) 493-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Medicaid work
$6,060 in 2024
Medicaid paid $6,060 for 251 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DETERMINATION REFRACTIVE STATE | 219 | $3,411 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 32 | $2,649 |
| 2024 | 251 | 2 | 25 | $6,060 |
| 2023 | 150 | 2 | 24 | $39 |
| 2022 | 164 | 3 | 24 | $0 |
| 2021 | 93 | 1 | 20 | $7 |
| 2020 | 26 | 1 | 14 | $0 |
| 2019 | 98 | 1 | 20 | $0 |
| 2018 | 73 | 1 | 18 | $0 |
See the largest Medicaid services in earlier years
2023
| DETERMINATION REFRACTIVE STATE | 138 | $39 |
| INTRM OPH EXAM NEW PATIENT | 12 | $0 |
2022
| INTRM OPH EXAM NEW PATIENT | 17 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $0 |
| DETERMINATION REFRACTIVE STATE | 135 | $0 |
2021
| DETERMINATION REFRACTIVE STATE | 93 | $7 |
2020
| DETERMINATION REFRACTIVE STATE | 26 | $0 |
2019
| DETERMINATION REFRACTIVE STATE | 98 | $0 |
2018
| DETERMINATION REFRACTIVE STATE | 73 | $0 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 12 Part D prescriptions in 2020. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 12 | None | 0% (0) | None | $2,012 |
| 2019 | 20 | 15 | 0% (0) | None | $2,065 |
| 2018 | 12 | None | 0% (0) | None | $308 |
| 2017 | 16 | 15 | 0% (0) | None | $462 |
| 2016 | 13 | None | 0% (0) | None | $1,252 |
| 2014 | 23 | None | 0% (0) | 78% | $5,267 |
| 2013 | 22 | 13 | 0% (0) | 86% | $5,318 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2013: 1 drug
| Restasis | 15 | $4,628 | $309 |
Money from drug and device companies
$125 in 2022
| 2022 | 1 | 1 | None | $125 |
| 2020 | 1 | 1 | None | $17 |
| 2019 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Saxenda | $125 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2022-07-25 | Saxenda | $125 |
See earlier years (2020, 2019)
2020: $17
| Carl Zeiss Meditec | None Specified | $17 | 1 payment
|
2019: $12
| Alcon Vision | Dailies | $12 | 1 payment
|
Professional record
- NPI
- 1679687982
- Licence
- CA 12079T
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- Po Box 431, Alviso, CA, 95002
- NPI first listed
- 2006-08-17
- NPI last updated
- 2022-01-03
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.